TOKYO -- U.S. drugmaker Pfizer on Friday applied to Japan's Ministry of Health for approval of its coronavirus vaccine, the company announced. The pharmaceutical giant is the first supplier to seek formal approval in Japan and has already agreed to supply the country with 120 million doses, enough for 60 million people.
Coronavirus
Pfizer applies for Japan COVID-19 vaccine approval
Inoculations set to begin by March after 'thorough' vetting process
The Pfizer-BioNTech COVID-19 vaccine has already received approval for emergency use in several countries, including the U.S., UK, and Singapore. © Reuters
Read Next
Latest on Coronavirus
